Uniquity Bio
Malvern
About Uniquity Bio
Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines, particularly in immunology and inflammation. The company utilizes leadership from experienced pharmaceutical executives to effectively drive its research and development efforts. Uniquity Bio has been backed by investments from notable entities, helping it to pursue its innovative drug development goals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $300.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: uniquity.com
- Phone: +1 858-422-0070
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/uniquity-bio-47762 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.